{"id":70789,"date":"2026-05-12T11:08:40","date_gmt":"2026-05-12T11:08:40","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70789"},"modified":"2026-10-15T10:33:57","modified_gmt":"2026-10-15T10:33:57","slug":"ahk-cu","status":"publish","type":"product","link":"https:\/\/medsbase.com\/pt-br\/product\/ahk-cu\/","title":{"rendered":"AHK-Cu"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Resposta R\u00e1pida \u2014 O que \u00e9 AHK-Cu?<\/h3>\n<p style=\"margin: 0;\"><strong>AHK-Cu<\/strong> (Complexo de Alanyl-Histidyl-Lysine Cobre(II)) \u00e9 um tripept\u00eddeo sint\u00e9tico ligante de cobre e a mol\u00e9cula irm\u00e3 do <a href=\"https:\/\/medsbase.com\/pt-br\/ghk-cu\/\">GHK-Cu<\/a>. While GHK-Cu is the canonical skin and wound-healing copper peptide, AHK-Cu&#8217;s signal is concentrated in <strong>biologia do fol\u00edculo capilar<\/strong> \u2014 published preclinical work documents stimulation of dermal papilla cells, follicular enlargement, increased follicular vascularization, and prolongation of the anagen growth phase. Supplied in 20\u00a0mg and 50\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>O que voc\u00ea obt\u00e9m com a MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/pt-br\/reviews\/\">\ud83d\udce6 Cada pedido \u00e9 coberto pela nossa<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Todo pedido \u00e9 coberto pelo nosso <a href=\"https:\/\/medsbase.com\/pt-br\/medsbase-re-shipment-assurance-policy\/\"><strong>Pol\u00edtica de Reenvio Garantido<\/strong><\/a> \u2014 se sua encomenda n\u00e3o chegar em 20 dias \u00fateis, n\u00f3s a reenviamos.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especifica\u00e7\u00e3o<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalhe<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">110374-12-4 (AHK-Cu); 71567-06-1 (pept\u00eddeo livre AHK)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>15<\/sub>H<sub>25<\/sub>CuN<sub>6<\/sub>O<sub>4<\/sub> (Complexo de cobre 1:1)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">~417 Da (complexo de cobre)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequ\u00eancia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Ala-His-Lys (AHK, 3 amino\u00e1cidos) coordenado a um \u00fanico Cu<sup>2+<\/sup> \u00edon via o nitrog\u00eanio do imidazol da His, o terminal amino da Ala e o nitrog\u00eanio pept\u00eddico desprotonado entre Ala e His<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Complexo de cobre-pept\u00eddeo liofilizado (p\u00f3 azul a azul-violeta; a cor vem das transi\u00e7\u00f5es d-d do Cu ligado)<sup>2+<\/sup>)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificado por HPLC, COA sob solicita\u00e7\u00e3o)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Armazenamento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizado: 2\u20138 \u00b0C (geladeira) para estoque de trabalho; \u221220 \u00b0C para armazenamento de longo prazo de frascos fechados. Reconstitu\u00eddo: 2\u20138 \u00b0C, usar em at\u00e9 ~30 dias. Proteger da luz. N\u00e3o congelar e descongelar a solu\u00e7\u00e3o reconstitu\u00edda.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidade<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u00c1gua bacteriost\u00e1tica (recomendada) ou \u00e1gua est\u00e9ril para janelas de uso mais curtas. Sol\u00favel em \u00e1gua; a solu\u00e7\u00e3o dissolvida mant\u00e9m a cor azul caracter\u00edstica do Cu ligado<sup>2+<\/sup>.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>O Que \u00c9 AHK-Cu?<\/h2>\n<p><strong>AHK-Cu<\/strong> (Complexo de Cobre(II) Alanil-Histidil-Lisina) \u00e9 um tripept\u00eddeo sint\u00e9tico ligante de cobre composto pelos tr\u00eas amino\u00e1cidos Ala, His e Lis, coordenados a um \u00fanico Cu<sup>2+<\/sup> \u00edon. \u00c9 a mol\u00e9cula irm\u00e3 do mais extensivamente estudado <a href=\"https:\/\/medsbase.com\/pt-br\/ghk-cu\/\">GHK-Cu<\/a> \u2014 both belong to the &#8220;copper peptide&#8221; class, both share the same Cu-coordination architecture using a histidine residue, and both are studied in dermatological contexts. Where they diverge is in primary signal: GHK-Cu is the canonical peptide for skin remodelling, wound healing, and connective-tissue repair, while AHK-Cu&#8217;s most-cited applications are in <strong>biologia do fol\u00edculo capilar<\/strong>. The well-characterised molecular composition is C<sub>15<\/sub>H<sub>25<\/sub>CuN<sub>6<\/sub>O<sub>4<\/sub>, peso molecular aproximadamente 417 Da. O Cu<sup>2+<\/sup> ion coordinates with the tripeptide via the imidazole nitrogen of histidine, the amino terminus of alanine, and the deprotonated peptide nitrogen between Ala and His \u2014 the same square-planar coordination geometry as in GHK-Cu. The bound copper gives both compounds their characteristic blue-to-violet colour in solid and dissolved form \u2014 users reconstituting AHK-Cu should expect a visibly blue working solution. AHK-Cu is supplied as a high-purity lyophilized copper-peptide complex for reconstitution with bacteriostatic water. The compound is <strong>n\u00e3o aprovado<\/strong> by the FDA, EMA, MHRA, or any other major regulator for human therapeutic use. For the sister skin-studies copper peptide, see our <a href=\"https:\/\/medsbase.com\/pt-br\/ghk-cu\/\">GHK-Cu<\/a> p\u00e1gina de produto. <\/p>\n<h2>Mecanismo de A\u00e7\u00e3o \u2014 Entrega de Cobre \u00e0s C\u00e9lulas da Papila do Fol\u00edculo Piloso<\/h2>\n<p>O que torna o AHK-Cu mecanicamente distinto entre os pept\u00eddeos de cobre \u00e9 sua <strong>sinaliza\u00e7\u00e3o preferencial nas c\u00e9lulas da papila d\u00e9rmica<\/strong> in the hair follicle \u2014 the mesenchymal cells at the base of each follicle that regulate hair-shaft production and cycle through the growth (anagen), regression (catagen), and rest (telogen) phases. Published studies has documented three principal mechanisms:<\/p>\n<ul>\n<li><strong>Entrega de cobre \u00e0s c\u00e9lulas da papila d\u00e9rmica<\/strong> \u2014 O \u00edon Cu<sup>2+<\/sup> ion is the active payload of AHK-Cu (and of GHK-Cu in skin studies). The tripeptide is a vehicle that ferries the metal ion into target tissue, where copper participates in multiple enzyme cofactor roles including lysyl oxidase (collagen and elastin cross-linking) and superoxide dismutase (oxidative-stress buffering). At the hair follicle, dermal papilla cells take up copper from AHK-Cu and use it to support the follicular extracellular matrix and oxidative-stress management that anagen requires.<\/li>\n<li><strong>Upregula\u00e7\u00e3o de VEGF e vasculariza\u00e7\u00e3o folicular<\/strong> \u2014 O AHK-Cu estimula a express\u00e3o do fator de crescimento endotelial vascular (VEGF) nas c\u00e9lulas da papila d\u00e9rmica. O efeito subsequente \u00e9 o aumento da perfus\u00e3o folicular \u2014 crescimento de novos capilares na base do fol\u00edculo que suportam as demandas metab\u00f3licas dos queratin\u00f3citos da matriz capilar em r\u00e1pida prolifera\u00e7\u00e3o durante a fase an\u00e1gena. Esse mecanismo de melhoria da perfus\u00e3o se sobrep\u00f5e ao mecanismo do minoxidil, mas opera por um caminho fundamentalmente diferente (sinaliza\u00e7\u00e3o direta de pept\u00eddeo de cobre em vez de modula\u00e7\u00e3o de canais de pot\u00e1ssio sens\u00edveis ao ATP).<\/li>\n<li><strong>Prolongamento da fase an\u00e1gena e aumento do fol\u00edculo<\/strong> \u2014 In published rodent hair-cycle studies, AHK-Cu administration prolongs the duration of the anagen growth phase and increases overall follicular size. The combined effect is more hair-shaft production per follicle per cycle. The mechanism appears to be downstream of the copper-delivery and VEGF-upregulation steps \u2014 healthy, well-perfused follicles in a copper-replete environment sustain anagen for longer before transitioning to catagen.<\/li>\n<\/ul>\n<p>The mechanism is fundamentally different from the two FDA-approved hair-loss compounds: finasteride blocks 5-alpha-reductase to lower scalp DHT (hormonal mechanism); minoxidil opens ATP-sensitive potassium channels to vasodilate follicular vessels (vascular mechanism). AHK-Cu provides direct mesenchymal-cell signalling and copper-cofactor delivery, working at a different point in follicular biology than either FDA-approved compound \u2014 which makes it a useful tool for dissecting follicular cell biology independent of androgen-axis or vasodilation-mediated mechanisms. Subcutaneous, topical, and intrafollicular injection routes are all documented in published studies. <\/p>\n<h2>Published Evidence<\/h2>\n<p>AHK-Cu is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Hair follicle biology studies<\/strong> \u2014 dermal papilla cell proliferation assays, follicular size measurement, hair-shaft diameter analysis, organ-cultured hair follicle studies; canonical copper-peptide compound for the hair-axis (Pyo et al., J Korean Med Sci 2007; Uno &amp; Kurata, J Investig Dermatol)<\/li>\n<li><strong>Hair cycle studies<\/strong> \u2014 dura\u00e7\u00e3o das fases an\u00e1gena\/cat\u00e1gena\/tel\u00f3gena, indu\u00e7\u00e3o de an\u00e1gena em fol\u00edculos tel\u00f3genos, resposta dose-resposta comparativa com compostos comparadores estabelecidos no eixo capilar<\/li>\n<li><strong>Follicular vascularization studies<\/strong> \u2014 express\u00e3o de VEGF, densidade capilar na base do fol\u00edculo, medi\u00e7\u00e3o de perfus\u00e3o peri-folicular<\/li>\n<li><strong>Comparative copper peptide studies<\/strong> \u2014 frente a frente com <a href=\"https:\/\/medsbase.com\/pt-br\/ghk-cu\/\">GHK-Cu<\/a> for dermatological studies; AHK-Cu favoured for hair-axis endpoints, GHK-Cu favoured for skin\/wound\/anti-aging endpoints<\/li>\n<li><strong>Topical and intradermal formulation studies<\/strong> \u2014 AHK-Cu is one of the more-studied copper peptides for topical and intradermal delivery; published studies investigates skin-penetration depth, follicular targeting via different vehicle formulations<\/li>\n<li><strong>Dissec\u00e7\u00e3o de mecanismos de queda de cabelo<\/strong> \u2014 alongside finasteride (androgen-axis) and minoxidil (vascular axis), AHK-Cu provides a third orthogonal studies mechanism (mesenchymal-cell + copper-cofactor + VEGF axis); useful for mechanism-of-action studies designs<\/li>\n<li><strong>Collagen and elastin studies<\/strong> \u2014 copper&#8217;s role as cofactor for lysyl oxidase makes copper peptides relevant to studies on extracellular matrix crosslinking; AHK-Cu shares this mechanism with GHK-Cu at the broader level although hair-axis effects predominate.<\/li>\n<\/ul>\n<p>For broader context on where AHK-Cu fits within the copper-peptide and dermatological studies landscape, see <a href=\"https:\/\/medsbase.com\/pt-br\/ghk-cu\/\">GHK-Cu<\/a> as the canonical skin-studies copper peptide, <a href=\"https:\/\/medsbase.com\/pt-br\/bpc-157\/\">BPC-157<\/a> for tissue-repair studies, and <a href=\"https:\/\/medsbase.com\/pt-br\/tb-500\/\">TB-500<\/a> for systemic recovery. Browse the full <a href=\"https:\/\/medsbase.com\/pt-br\/peptides\/\">cat\u00e1logo de pept\u00eddeos<\/a> para compostos relacionados. <\/p>\n<h2>Concentra\u00e7\u00f5es e Dosagens Dispon\u00edveis<\/h2>\n<p>MedsBase stocks AHK-Cu in two lyophilized vial sizes calibrated to typical protocol lengths. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats with full reconstitution guidance:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Dosagem do Frasco<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso de Uso T\u00edpico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tamanhos de Embalagem<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>20 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength \u2014 topical formulation and short-cycle protocols<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>50 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Bulk packs vial, extended cycles, lowest per-mg cost, multi-cohort follicle studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Both strengths are the same chemical form (lyophilized copper-peptide complex, 99%+ HPLC purity). Higher-mg vials are particularly useful for AHK-Cu because of the relatively large doses typical in topical-formulation studies compared with the microgram-range systemic peptides. Higher-mg vials require smaller reconstitution volumes per unit dose. <\/p>\n<h2>Como Comparar \u2014 AHK-Cu vs GHK-Cu<\/h2>\n<p>AHK-Cu e <a href=\"https:\/\/medsbase.com\/pt-br\/ghk-cu\/\">GHK-Cu<\/a> are sister copper-binding tripeptides that share the same Cu-coordination chemistry but differ in the first amino-acid residue (Ala vs Gly). This minor structural difference produces qualitatively different signals: GHK-Cu dominates skin\/wound\/anti-aging studies while AHK-Cu&#8217;s strongest signal is in hair follicle biology. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Crit\u00e9rio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">AHK-Cu<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">GHK-Cu<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Comprimento<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">3 amino\u00e1cidos (tripept\u00eddeo)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">3 amino\u00e1cidos (tripept\u00eddeo)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Sequ\u00eancia<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ala-His-Lys<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Gly-His-Lys<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Coordena\u00e7\u00e3o de cobre<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1:1 Cu<sup>2+<\/sup> via His + N-terminal<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1:1 Cu<sup>2+<\/sup> via His + N-terminal<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Primary signal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Biologia do fol\u00edculo piloso, prolongamento da fase an\u00e1gena<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Remodela\u00e7\u00e3o da pele, cicatriza\u00e7\u00e3o de feridas, antienvelhecimento<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Tipo de c\u00e9lula alvo<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">C\u00e9lulas da papila d\u00e9rmica (fol\u00edculo piloso)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Fibroblastos d\u00e9rmicos, queratin\u00f3citos (pele)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Sinaliza\u00e7\u00e3o de VEGF<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Forte \u2014 vasculariza\u00e7\u00e3o folicular<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Moderada \u2014 angiog\u00eanese no leito da ferida<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Ocorr\u00eancia end\u00f3gena<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Sint\u00e9tico (sem pool end\u00f3geno significativo)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">End\u00f3geno (diminui com a idade no plasma)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Dose t\u00edpica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">2\u201310 mg t\u00f3pico \/ 1\u20135 mg subcut\u00e2neo<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1\u20135 mg t\u00f3pico \/ 0,5\u20132 mg subcut\u00e2neo<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For hair-axis studies, AHK-Cu is the canonical first choice because of the dermal-papilla-cell selectivity and the documented anagen-prolongation signal. For skin remodelling, wound healing, and anti-aging studies, <a href=\"https:\/\/medsbase.com\/pt-br\/ghk-cu\/\">GHK-Cu<\/a> is the canonical reference. Some studies designs use both in parallel arms to dissect copper-peptide effects that are shared (general Cu cofactor delivery) from effects that are sequence-specific (cell-type selectivity). <\/p>\n<h2>Armazenamento e Reconstitui\u00e7\u00e3o<\/h2>\n<p><strong>Antes da reconstitui\u00e7\u00e3o:<\/strong> armazene os frascos liofilizados refrigerados a 2\u20138 \u00b0C na embalagem original para estoque de trabalho de curto prazo. Para armazenamento de longo prazo n\u00e3o aberto, congele a \u221220 \u00b0C. O AHK-Cu liofilizado \u00e9 est\u00e1vel sob refrigera\u00e7\u00e3o por at\u00e9 24 meses e a \u221220 \u00b0C por at\u00e9 36 meses. Evite ciclos de congelamento-descongelamento no p\u00f3 liofilizado. A coordena\u00e7\u00e3o do Cu<sup>2+<\/sup> \u00e9 est\u00e1vel na forma liofilizada; uma vez reconstitu\u00eddo, a exposi\u00e7\u00e3o prolongada \u00e0 luz ou agentes redutores pode afetar o estado de oxida\u00e7\u00e3o do cobre. <strong>Procedimento de reconstitui\u00e7\u00e3o:<\/strong> injete \u00e1gua bacteriost\u00e1tica pela parede lateral do frasco do pept\u00eddeo (n\u00e3o diretamente sobre o p\u00f3 liofilizado). Para um frasco de 20 mg, 2,0 mL de \u00e1gua bacteriost\u00e1tica produzem uma concentra\u00e7\u00e3o de trabalho de 10 mg\/mL \u2014 0,1 mL fornece 1 mg; 0,5 mL fornece 5 mg. Agite suavemente \u2014 n\u00e3o <strong>n\u00e3o<\/strong> agite \u2014 e aguarde 2\u20135 minutos para dissolu\u00e7\u00e3o completa. Uma solu\u00e7\u00e3o corretamente reconstitu\u00edda deve estar l\u00edmpida com a caracter\u00edstica cor azul do Cu ligado.<sup>2+<\/sup>. Turva\u00e7\u00e3o ou precipitado indica um problema na reconstitui\u00e7\u00e3o; descarte e tente novamente. <strong>Ap\u00f3s a reconstitui\u00e7\u00e3o:<\/strong> store refrigerated at 2\u20138\u00a0\u00b0C and use within 30 days for optimal stability. Do not freeze the reconstituted solution \u2014 freeze-thaw cycles degrade peptide integrity. Protect from direct light at all times. For topical formulation studies, AHK-Cu can be incorporated into a wide range of vehicles (creams, gels, serums) for follicle-studies delivery; published vehicle studies includes liposomal and microemulsion formulations for enhanced follicular penetration. <\/p>\n<h2 id=\"faqs\">Perguntas Frequentes<\/h2>\n<h3>What is AHK-Cu used for in studies?<\/h3>\n<p>AHK-Cu is used in studies investigating hair follicle biology, dermal papilla cell proliferation, anagen phase prolongation, follicular vascularization, hair-shaft diameter, comparative copper-peptide pharmacology, topical and intradermal formulation studies, and mechanism-of-action dissection of hair-loss biology distinct from the androgen-axis (finasteride) and vascular (minoxidil) mechanisms. It is the canonical copper-peptide compound for the hair-axis. The pharmaceutical-grade AHK-Cu sold here is <strong>n\u00e3o<\/strong> FDA-approved and is supplied strictly for clinical studies use only. <\/p>\n<h3>Como o AHK-Cu difere do GHK-Cu?<\/h3>\n<p>Ambos s\u00e3o tripept\u00eddeos ligantes de cobre que compartilham a mesma arquitetura de coordena\u00e7\u00e3o de Cu (Cu 1:1 mediado por His)<sup>2+<\/sup> binding). They differ in the first amino-acid residue \u2014 alanine in AHK-Cu, glycine in GHK-Cu \u2014 producing different cell-type selectivity in published studies. AHK-Cu&#8217;s strongest signal is in dermal papilla cells of the hair follicle; <a href=\"https:\/\/medsbase.com\/pt-br\/ghk-cu\/\">GHK-Cu<\/a>\u2018O sinal mais forte de \u2018s est\u00e1 nos fibroblastos e queratin\u00f3citos da pele. Os dois s\u00e3o frequentemente estudados em paralelo para dissociar os efeitos compartilhados dos pept\u00eddeos de cobre dos efeitos espec\u00edficos da sequ\u00eancia. <\/p>\n<h3>What is the typical AHK-Cu dose?<\/h3>\n<p>Published preclinical protocols typically use 1\u20135\u00a0mg per administration for subcutaneous delivery and 2\u201310\u00a0mg for topical formulation studies, given 1\u20133 times daily for 4\u201312 week cycles. A 20\u00a0mg vial reconstituted with 2.0\u00a0mL bacteriostatic water yields 10\u00a0mg\/mL \u2014 0.1\u00a0mL equals 1\u00a0mg, 0.5\u00a0mL equals 5\u00a0mg. <\/p>\n<h3>N\u00e3o. O AHK-Cu n\u00e3o \u00e9 aprovado pela FDA, EMA, MHRA ou qualquer outro regulador importante para uso terap\u00eautico em humanos. Pept\u00eddeos de cobre foram incorporados em alguns produtos cosm\u00e9ticos sob regulamenta\u00e7\u00f5es cosm\u00e9ticas, mas o AHK-Cu especificamente n\u00e3o tem aprova\u00e7\u00e3o terap\u00eautica. Todo o AHK-Cu vendido por fornecedores apenas para pesquisa \u00e9 destinado a investiga\u00e7\u00f5es laboratoriais e n\u00e3o deve ser administrado em humanos.<\/h3>\n<p>No. AHK-Cu is not approved by the FDA, EMA, MHRA, or any other major regulator for human therapeutic use. Copper peptides have been incorporated into some cosmetic products under cosmetic-regulation frameworks, but AHK-Cu specifically has no therapeutic approval. <\/p>\n<h3>Frascos liofilizados: refrigerados a 2\u20138 \u00b0C para estoque de trabalho de curto prazo, ou \u221220 \u00b0C para armazenamento de longo prazo de frascos n\u00e3o abertos. Solu\u00e7\u00e3o reconstitu\u00edda: refrigerada a 2\u20138 \u00b0C, usar dentro de 30 dias. N\u00e3o congele a solu\u00e7\u00e3o reconstitu\u00edda \u2014 ciclos de congelamento e descongelamento degradam o pept\u00eddeo e podem afetar a coordena\u00e7\u00e3o do cobre. Proteja da luz direta em todos os momentos para preservar o estado de oxida\u00e7\u00e3o do cobre.<\/h3>\n<p>Frascos liofilizados: refrigerados a 2\u20138 \u00b0C para estoque de trabalho de curto prazo, ou \u221220 \u00b0C para armazenamento de longo prazo de frascos n\u00e3o abertos. Solu\u00e7\u00e3o reconstitu\u00edda: refrigerada a 2\u20138 \u00b0C, usar dentro de 30 dias. N\u00e3o congele a solu\u00e7\u00e3o reconstitu\u00edda \u2014 ciclos de congelamento e descongelamento degradam o pept\u00eddeo e podem afetar a coordena\u00e7\u00e3o do cobre. Proteja da luz direta o tempo todo para preservar o estado de oxida\u00e7\u00e3o do cobre. <\/p>\n<h3>Agite o frasco. Uma solu\u00e7\u00e3o corretamente reconstitu\u00edda \u00e9 clara com a caracter\u00edstica cor azul do Cu ligado \u2014 a cor em si confirma a reconstitui\u00e7\u00e3o bem-sucedida e a coordena\u00e7\u00e3o do cobre intacta. Para um frasco de 20 mg + 2,0 mL de diluente, a concentra\u00e7\u00e3o de trabalho \u00e9 de 10 mg\/mL.<\/h3>\n<p>Siga o procedimento de reconstitui\u00e7\u00e3o acima. Adicione \u00e1gua bacteriost\u00e1tica pela parede lateral do frasco (n\u00e3o diretamente sobre o liofilizado), agite suavemente e aguarde 2\u20135 minutos para dissolu\u00e7\u00e3o completa. N\u00e3o <strong>n\u00e3o<\/strong> agite o frasco. Uma solu\u00e7\u00e3o corretamente reconstitu\u00edda \u00e9 clara com a caracter\u00edstica cor azul do Cu ligado<sup>2+<\/sup> \u2014 a pr\u00f3pria cor confirma a reconstitui\u00e7\u00e3o bem-sucedida e a coordena\u00e7\u00e3o intacta do cobre. Para um frasco de 20 mg + 2,0 mL de diluente, a concentra\u00e7\u00e3o de trabalho \u00e9 de 10 mg\/mL. <\/p>\n<h3>Quais dosagens a MedsBase oferece?<\/h3>\n<p>MedsBase carries AHK-Cu in 20\u00a0mg and 50\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request. <\/p>\n<h3>Why is AHK-Cu blue in colour?<\/h3>\n<p>A caracter\u00edstica cor azul a violeta do AHK-Cu (e GHK-Cu) vem das transi\u00e7\u00f5es eletr\u00f4nicas d-d do Cu ligado<sup>2+<\/sup> no ambiente de coordena\u00e7\u00e3o quadrado-planar criado pelo res\u00edduo de histidina e pela estrutura pept\u00eddica. A cor \u00e9 um indicador qualitativo \u00fatil da coordena\u00e7\u00e3o bem-sucedida do cobre \u2014 uma solu\u00e7\u00e3o azul adequadamente reconstitu\u00edda confirma a presen\u00e7a de Cu intacto<sup>2+<\/sup> a liga\u00e7\u00e3o, enquanto uma solu\u00e7\u00e3o incolor ou p\u00e1lida indicaria perda ou degrada\u00e7\u00e3o do cobre. Isso \u00e9 \u00fanico entre os pequenos pept\u00eddeos \u2014 a maioria dos pept\u00eddeos sint\u00e9ticos produz solu\u00e7\u00f5es incolores quando reconstitu\u00eddos. <\/p>\n<h3>Como o AHK-Cu se compara \u00e0 finasterida ou ao minoxidil?<\/h3>\n<p>The three target hair-loss biology through completely different mechanisms. Finasteride blocks 5-alpha-reductase to lower scalp dihydrotestosterone (DHT) levels \u2014 an androgen-axis mechanism. Minoxidil opens ATP-sensitive potassium channels to vasodilate follicular vessels \u2014 a vascular mechanism. AHK-Cu provides direct copper-cofactor delivery and VEGF-mediated follicular vascularization at the dermal papilla cell level \u2014 a mesenchymal-cell mechanism. The three mechanisms are orthogonal, which makes AHK-Cu a useful tool for studying follicular biology independent of androgen-axis or vasodilation-mediated effects. <\/p>\n<h3>Does AHK-Cu cause side reported effects?<\/h3>\n<p>Published preclinical studies has reported a notably clean safety profile at typical doses, with the main on-target effect being follicular stimulation. Off-target findings can include local injection-site irritation and (with prolonged high-dose topical exposure) modest cutaneous discolouration from copper deposition \u2014 both reversible with discontinuation. Systemic adverse effects from topical applications are rare due to limited transcutaneous absorption. <\/p>\n<h3>Qual \u00e9 a meia-vida do AHK-Cu?<\/h3>\n<p>In preclinical studies, AHK-Cu has a relatively short plasma half-life (~1\u20132 hours) following subcutaneous administration. The short half-life is offset by retention of bound copper in target tissues \u2014 even after plasma clearance, the copper delivered to dermal papilla cells continues to support follicular biology through its enzyme-cofactor roles. Topical formulations provide sustained local exposure that is more relevant for hair-axis studies than the systemic plasma profile. <\/p>\n<h3>Can AHK-Cu and GHK-Cu be stacked in studies?<\/h3>\n<p>Yes. The two copper peptides target different cell types (dermal papilla for AHK-Cu, dermal fibroblasts for GHK-Cu) and address different studies domains (hair vs skin), so co-administration is not pharmacologically redundant. Study protocols studying combined skin-and-hair endpoints \u2014 for example, comprehensive dermatological remodelling studies \u2014 sometimes use both arms. <\/p>\n<h3>How long does AHK-Cu take to show effects in preclinical studies?<\/h3>\n<p>Acute effects on dermal papilla cell VEGF expression are detectable within 24\u201372 hours in cell-culture studies. Follicular size and anagen-prolongation effects in rodent hair-cycle models typically become statistically significant after 4\u20138 weeks of regular treatment and continue to accrue through 12\u201316 weeks \u2014 matching the natural hair-cycle timeframe. <\/p>\n<h3>Posso encomendar AHK-Cu para envio internacional?<\/h3>\n<p>Sim. A MedsBase envia AHK-Cu para todo o mundo atrav\u00e9s de nossa rede dedicada de envio de pept\u00eddeos. Pedidos contendo apenas pept\u00eddeos qualificam-se para nosso servi\u00e7o de envio exclusivo para pept\u00eddeos. Todos os pedidos s\u00e3o enviados em embalagens com controle de temperatura, com rastreamento completo e cobertura pelo nosso <a href=\"https:\/\/medsbase.com\/pt-br\/medsbase-re-shipment-assurance-policy\/\">Pol\u00edtica de Reenvio Garantido<\/a>. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Hair, Skin, and Tissue-Regeneration Studies<\/h2>\n<ul>\n<li><a href=\"\/pt-br\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Sister copper-binding tripeptide \u2014 canonical skin remodelling and wound-healing compound<\/li>\n<li><a href=\"\/pt-br\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tissue-regeneration and recovery<\/li>\n<li><a href=\"\/pt-br\/tb-500\/\"><strong>TB-500 (Thymosin Beta-4)<\/strong><\/a> \u2014 Systemic healing fragment \u2014 tissue and vascular recovery<\/li>\n<li><a href=\"\/pt-br\/epitalon\/\"><strong>Epitalon<\/strong><\/a> \u2014 AEDG pineal tetrapeptide \u2014 longevity and circadian rhythm support<\/li>\n<li><a href=\"\/pt-br\/semax\/\"><strong>Semax<\/strong><\/a> \u2014 Nootropic heptapeptide \u2014 CNS compound<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Leitura Adicional<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Explore the copper-peptide studies landscape<\/strong><\/p>\n<p style=\"margin: 0;\">Navegue pela categoria completa <a href=\"https:\/\/medsbase.com\/pt-br\/peptides\/\"><strong>cat\u00e1logo de pept\u00eddeos<\/strong><\/a>, com compostos relacionados em dermatologia e regenera\u00e7\u00e3o tecidual incluindo <a href=\"https:\/\/medsbase.com\/pt-br\/ghk-cu\/\">GHK-Cu<\/a> (sister copper peptide for skin studies), <a href=\"https:\/\/medsbase.com\/pt-br\/bpc-157\/\">BPC-157<\/a> (regenera\u00e7\u00e3o tecidual), e <a href=\"https:\/\/medsbase.com\/pt-br\/tb-500\/\">TB-500<\/a> (cura sist\u00eamica).<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Alanyl-Histidyl-Lysine Cobre(II) tripept\u00eddeo<br \/>\n\u2705 Mol\u00e9cula irm\u00e3 do GHK-Cu<br \/>\n\u2705 Hair follicle biology compound<br \/>\n\u2705 Estimula\u00e7\u00e3o de c\u00e9lulas da papila d\u00e9rmica, prolongamento da fase an\u00e1gena<br \/>\n\u2705 Ortogonal aos mecanismos de finasterida\/minoxidil<\/p>\n<p><strong>AHK-Cu<\/strong> cont\u00e9m complexo sint\u00e9tico de cobre-pept\u00eddeo.<\/p>","protected":false},"featured_media":70940,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6290,5441],"class_list":["post-70789","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-ahk-cu","product_tag-peptide","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product\/70789","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/comments?post=70789"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/media\/70940"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/media?parent=70789"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product_brand?post=70789"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product_cat?post=70789"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product_tag?post=70789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}